Clinical Trial Update: Terlipressin for Refractory Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial update for terlipressin in refractory septic shock, currently with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Mahidol University | Conditions: Septic Shock, Refractory Shock | Phase 2 | Status: UNKNOWN